Florida Cancer Specialists Career Growth & Development

Key Insight for Candidates

• Internal Mobility: Public announcements show multiple internal promotions, including executive roles (e.g., General Counsel, Chief Value & Procurement Officer) and expanded physician leadership posts. As a physician‑owned group, leadership roles are frequently filled by current physicians, indicating advancement pathways for internal talent.
• Training & Education Access: The Employee Tuition Assistance Program offers up to $5,250/year for full‑time staff ($2,625 part‑time) with degree, non‑degree, and certification options, updated in 2025 to align with IRS rules. Internal education summits and co‑hosted national events further signal ongoing learning opportunities.
• Exposure & Visibility: A large statewide footprint with nearly 100 locations and active clinical trials, including early‑phase access via Sarah Cannon partnerships and Drug Development Units, provides broad clinical and research exposure. High trial volume and collaborations (e.g., Lake Nona) can deepen experience with novel therapies and protocols.

• Unclear Advancement: Advancement appears strongest in physician and senior leadership tracks, while timelines and pathways for clinical support and administrative roles vary by site. Public materials highlight development but do not establish a blanket promote‑from‑within policy, making expectations role‑dependent.
• Lack of Learning & Training: Some clinics report minimal orientation and uneven onboarding depth, requiring proactive self‑study and mentorship seeking to progress. Day‑to‑day development can hinge on the local precepting model and manager engagement.
• Insufficient Resources: High stress, staffing gaps, and tighter PTO during busy seasonal months can limit time available for development. Workload intensity in community oncology can compress time for protected training unless the local team explicitly supports it.